0000001097 00000 n
0000006213 00000 n
Follow applicable special handling and disposal procedures Reduce the dose of DROXIA by 50% in patients with creatinine clearance of less than 60 mL/min or with end-stage renal disease (ESRD) Monitor the hematologic parameters closely in these patients.DROXIA is contraindicated in patients who have demonstrated a previous hypersensitivity to hydroxyurea or any other component of its formulation.Hydroxyurea causes severe myelosuppression. Medically reviewed by Drugs.com on Mar 24, 2020 – Written by Cerner Multum. Didanosine Images. Hydroxyurea is used to treat chronic myeloid leukemia, ovarian cancer, and certain types of skin cancer (squamous cell cancer of the head and neck). These are not all the possible side effects of efavirenz. Report Side Effects or Product Quality Complaints about Legacy Celgene Products (ABRAXANE 0000001394 00000 n
0000028298 00000 n
Didanosine and interferon medications are among the drugs that may potentially interact with Zerit. Company AZACTAM® (aztreonam) BARACLUDE® (entecavir) 2.2 Dose Modifications for Renal Impairment . <<75FE86922DEB66408FFCC8AC5384BACE>]/Prev 128234/XRefStm 1394>>
0000001583 00000 n
Sustiva. USE IN SPECIFIC POPULATIONS ... DROXIA ®, HYDREA ® ... Sustiva, Complera, Stribild, Reyataz, zidovudine, Atripla. 0000004787 00000 n
This form of pharmaceutical information is referred to in the pharmaceutical industry as a "package insert." Treatment with hydroxyurea should not be initiated if bone marrow function is markedly depressed. h�b```b``]���� ��A�X��,-� Patients must be able to follow directions regarding drug administration and their monitoring and care.Fetal hemoglobin (HbF) levels may be used to evaluate the efficacy of DROXIA in clinical use.
0000008575 00000 n
0000003189 00000 n
0000013913 00000 n
0000034907 00000 n
Follow applicable special handling and disposal procedures [see References (15)]. 0000003303 00000 n
Brief patient counseling information can be found in the Hydroxyurea (Hydrea) package insert; Hydroxyurea (Hydrea) patient drug information (Chemocare) Hydroxyurea (Hydrea) patient drug information (UpToDate) History of changes in FDA indication. In patients receiving long-term hydroxyurea for myeloproliferative disorders, secondary leukemia has been reportedBased on the mechanism of action and findings in animals, DROXIA can cause fetal harm when administered to a pregnant woman. xref
Consult package insert of the tetracycline. This page also describes the problems these interactions can cause, such as an increased risk of side effects. Source: Food and Drug Administration (FDA) 60 CAPSULES NDC 0003-6336-17 DROXIA ® (hydroxyurea capsules, USP) 300 mg per capsule Rx only Bristol-Myers … selected from the Reyataz,* Kaletra,*or Sustiva*anti-HIV agents. 497 39
startxref
Review this Drug No reviews. 0000008317 00000 n
0000028213 00000 n
0000007396 00000 n
Review this Drug No reviews. Provide supportive care and modify dose or discontinue DROXIA as needed. Obtain HbF levels every three to four months. 0000013056 00000 n
We were pretty excited as we boarded a new A350, bound for Doha. Monitor for an increase in HbF of at least two-fold over the baseline value.DROXIA causes macrocytosis, which may mask the incidental development of folic acid deficiency. This eMedTV Web page explores potential Videx drug interactions with other medications, such as certain antibiotics and methadone. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Sustiva (efavirenz) Skip to: full site navigation. The Food and Drug Administration recently approved revisions to the package insert for Sustiva (efavirenz), a non-nucleoside reverse transcriptase inhibitor, for both capsules and tablets, to include updates to the sections described below. Please click below to see the Full U.S. Prescribing Information, including We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases.